Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check7 days agoChange DetectedMelanoma and MedlinePlus Genetics were removed from the Related Topics section.SummaryDifference0.2%

- Check14 days agoChange DetectedAdded Melanoma as a condition keyword and included a related topics resource linking to MedlinePlus Genetics.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded Revision: v3.5.0; removed Melanoma, related topics: MedlinePlus Genetics, and Revision: v3.4.3.SummaryDifference0.3%

- Check29 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics). Updated revision to v3.4.3 and removed v3.4.2.SummaryDifference0.3%

- Check43 days agoChange DetectedRemoved Melanoma and related topics such as MedlinePlus Genetics from the Study Details page.SummaryDifference0.2%

- Check57 days agoChange DetectedSmall editorial updates were made, including adding Melanoma and related topics (MedlinePlus Genetics) and a new revision tag (v3.4.2), while the funding notice and the previous revision tag (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.